menu
    • menu

    Company profile for ValiRx

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ValiRx is a biotechnology oncology focused company specialising in developing novel therapeutics for cancer and associated biomarkers. It aims to make a significant contribution in “precision” medicine and science, namely to engineer a breakthrough into human health and well-being, through the early detection of cancer and its therapeutic intervention. The Company’s business model focuses on out-licensing therapeutic ...
    ValiRx is a biotechnology oncology focused company specialising in developing novel therapeutics for cancer and associated biomarkers. It aims to make a significant contribution in “precision” medicine and science, namely to engineer a breakthrough into human health and well-being, through the early detection of cancer and its therapeutic intervention. The Company’s business model focuses on out-licensing therapeutic candidates during the development process. By aiming for early-stage value creation, the company reduces risk considerably while increasing the potential for realising value.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ValiRxunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    180-186 Kings Cross Road London, WC1X 9DE
    Telephone
    Telephone
    +44 (0)207 0732628
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.valirx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Products Expo

    Natural Products Expo

    Not Confirmed

    envelop Contact Supplier

    Natural Products Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ValiRx Signs Lease Deal with Nottingham Laboratories
    ValiRx Signs Lease Deal with Nottingham Laboratories

    07 Feb 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-02-07/valirx-signs-lease-deal-with-nottingham-laboratories/?widget=listSection

    CONTRACT PHARMA
    07 Feb 2023
    Share Share
    ValiRx signs preliminary licence agreement with TheoremRx
    ValiRx signs preliminary licence agreement with TheoremRx

    02 Nov 2021

    // STOCKMARKETWIRE

    https://www.stockmarketwire.com/article/7220466/ValiRx-signs-preliminary-licence-agreement-with-TheoremRx.html

    STOCKMARKETWIRE
    02 Nov 2021
    Share Share
    ValiRx commences new evaluation agreement
    ValiRx commences new evaluation agreement

    16 Sep 2021

    // INVESTEGATE

    https://www.investegate.co.uk/valirx-plc--val-/rns/new-evaluation-agreement/202109160700029162L/

    INVESTEGATE
    16 Sep 2021
    Share Share
    ValiRx plc Extension of Collaboration Agreement
    ValiRx plc Extension of Collaboration Agreement

    17 Feb 2021

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2021-02-17/valirx-plc-extension-of-collaboration-agreement

    PHARMIWEB
    17 Feb 2021
    Share Share
    Oncology consultancy Physiomics signs new agreement with ValiRx
    Oncology consultancy Physiomics signs new agreement with ValiRx

    16 Feb 2021

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/oncology-consultancy-physiomics-signs-new-agreement-with-valirx/

    CLINICALTRIALSARENA
    16 Feb 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search